Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Artechouse's Newest Exhibition Uses Latest NASA Images
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Load More